Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02898584 · ClinicalTrials.gov registry record · NA

Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care

A NA study of Hypertension, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT02898584 is a NA study of Hypertension that has completed, run by University of Michigan. The registered enrollment target is 16 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02898584, a NA study of Hypertension, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test the feasibility, acceptability, and preliminary effectiveness of the use of a mobile pharmacist-led intervention that incorporates home BP monitoring and medication reminders with patients recruited from a primary care setting, as well as identify challenges and potential solutions to broader implementation of a mobile pharmacist-led home-based BP monitoring intervention in primary care clinics through key stakeholder interviews.

Conditions Studied

Interventions

  • OTHER BP Track

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2016-10
Est. Completion 2020-06
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02898584

The ClinicalTrials.gov registry entry for NCT02898584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which BP Track is the first listed.

NCT02898584 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02898584 about?

NCT02898584 is a clinical study titled "Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care". The purpose of this research study is to test the feasibility, acceptability, and preliminary effectiveness of the use of a mobile pharmacist-led intervention that incorporates home BP monitoring and medication reminders with patients recruited from a primary care setting, as well as identify challe...

What is the current status of trial NCT02898584?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-10. Estimated completion is 2020-06.

What conditions does trial NCT02898584 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT02898584?

The interventions under investigation include: BP Track (OTHER).

Who is sponsoring clinical trial NCT02898584?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02898584 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.